Education
About Us
Working with TipRanks
Follow Us
Sharp Therapeutics Corp. (TSE:SHRX)
:SHRX
SHRX Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.50 - C$2.30
Previous CloseN/A
VolumeN/A
Average Volume (3M)203.00
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.13
Next Earnings
Nov 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding15,413,691
10 Day Avg. Volume230
30 Day Avg. Volume203
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Sharp Therapeutics Corp. News
SHRX FAQ
What was Sharp Therapeutics Corp.’s price range in the past 12 months?
Sharp Therapeutics Corp. lowest stock price was C$0.50 and its highest was C$2.30 in the past 12 months.
What is Sharp Therapeutics Corp.’s market cap?
Currently, no data Available
When is Sharp Therapeutics Corp.’s upcoming earnings report date?
Sharp Therapeutics Corp.’s upcoming earnings report date is Nov 27, 2025 which is in 62 days.
How were Sharp Therapeutics Corp.’s earnings last quarter?
Currently, no data Available
Is Sharp Therapeutics Corp. overvalued?
According to Wall Street analysts Sharp Therapeutics Corp.’s price is currently Overvalued.
Does Sharp Therapeutics Corp. pay dividends?
Sharp Therapeutics Corp. does not currently pay dividends.
What is Sharp Therapeutics Corp.’s EPS estimate?
Sharp Therapeutics Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sharp Therapeutics Corp. have?
Sharp Therapeutics Corp. has 15,413,691 shares outstanding.
What happened to Sharp Therapeutics Corp.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Sharp Therapeutics Corp.?
Currently, no hedge funds are holding shares in TSE:SHRX
Company Description
Sharp Therapeutics Corp.
EVP Capital Inc. is a Canada-based capital pool company. The principal business of the Company is the identification and evaluation of assets or businesses with a view to completing a qualifying transaction (QT). It has not commenced operations and has not generated any revenue.
Technical Analysis
Advanced Proteome Therapeutics
―
NanoSphere Health Sciences Inc
―
Core One Labs
―
Appili Therapeutics Inc Class A
―
WPD Pharmaceuticals
―
Options Prices
Currently, No data available
---